Daiichi Sankyo To Step In To Oversee Ranbaxy Manufacturing
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo Co Ltd plans to send personnel to oversee operations at Ranbaxy Laboratories Ltd. manufacturing facilities to resolve U.S. FDA GMP violations, the company said during its earnings call Jan. 31.